Letters to the Editor

Repurposing CD19-directed immunotherapies for pediatric t(8;21) acute myeloid leukemia

Princess Máxima Center for Pediatric Oncology, Utrecht
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; Erasmus MC-Sophia Children's Hospital, Department of Pediatric Oncology, Rotterdam
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit, Department of Pediatric Oncology, Amsterdam
Princess Máxima Center for Pediatric Oncology, Utrecht
Princess Máxima Center for Pediatric Oncology, Utrecht
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht
Princess Máxima Center for Pediatric Oncology, Utrecht
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht
Princess Máxima Center for Pediatric Oncology, Utrecht
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; Wilhelmina Children’s Hospital/University Medical Center, Utrecht
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; Erasmus MC-Sophia Children's Hospital, Department of Pediatric Oncology, Rotterdam
Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht
Department of Hematology, Amsterdam UMC, Location VUMC, Cancer Center Amsterdam
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit, Department of Pediatric Oncology, Amsterdam
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom; University Medical Center Utrecht, Utrecht University, Utrecht
Haematologica Early view Aug 8, 2024 https://doi.org/10.3324/haematol.2024.285707